RhD in Pregnancy

Non-Invasive Prenatal Testing (NIPT) for RHD may be used to determine whether an RhD negative woman carries an RhD positive fetus and threrefore requires RhD immunoglobulin prophylaxis. These were developed by ANZSBT and collaborators with the support of Australian Government Department of Health Quality Use of Pathology Program. Resources are free to use and adapt to local requirements with acknowledgement of the source.

Guidance for RHD NIPT can be found on the ANZSBT Guidelines Page.

For more information please see the ANZSBT RhD NIPT website below

Check with your local laboratories for availability of RHD NIPT.

Visit RHD NIPT Website

Educational Resources

Educational Resources

Online information for consumers, clincians and laboratories is available on the ANZSBT webportal

Podcast on RHD NIPT for health professionals (29 minutes) with Tani Paxton (Australian College of Midwives (ACM)) & Dr Ania Samarawickrama (Royal Australian College of General Practitioners (RACGPs)) – listen here

Powerpoint slides to kickstart your presentation for health professional education – download here

Australian College of Midwives / ANZSBT elearning: As part of the QUPP sponsored project, ANZSBT has been proud to partner with the Australian College of Midwives to co-developed an elearning module. The course is free and a certicate can be issued on successful completion. Hosted by the Australian College of Midwives, the course may accessed here.

Printable Resources for Consumers and Consumer Engagement

NIPT Postcard A6

NIPT Poster

NIPT 2 Page Brochure

NIPT 6 Page Folded Brochure

Clinical Pathways

Clinical pathways designed to assist in clinical implementation, sample flow, result communication and interpretation.

Flow Pathway for RHD NIPT in pregnancy -extended

Flow Pathway for RHD NIPT in pregnancy – portrait

Flow Pathway for RHD negative women without antibodies

Flow Pathway for women with weak or partial RhD

Flow Pathway for RhD Ig prophylaxis and NIPT results

Flow Pathway for specimen management in laboratories

Audit and Implementation Tools

Failure Mode and Effects Analysis (FMEA)

Clinician Survey

Audit Tool

Acknowledgements

ANZSBT acknowledge the contributions of stakeholders from health professions and consumers in the development of these tools and guidelines. The contributions of the Project Manager, Project Officer and Steering Committee and the funding from the Australian Government are particularly acknowledged.

Project Steering Committee

A/Prof Philip Crispin	Steering Committee Chair
Prof David Roxby	Project Manager
Kristen Brown	Project Officer
Dr (Jerry) Abraham Alex	Australian College of Rural and Remote Medicine (ACRRM)
Simon Benson	President, ANZSBT
Dr James Daly	Australian Red Cross Lifeblood (ARCLB)
Prof Wendy Erber	Professor of Pathology and Laboratory Medicine
Dr Shin Lee	Royal Australian & New Zealand College of Obstetrics and Gynaecology (RANZCOG)
Dr Ellen Maxwell	Royal College of Pathologists of Australasia (RCPA)
Tani Paxton	Australian College of Midwives (ACM)
Dr Ania Samarawickrama	Royal Australian College of General Practitioners (RACGPs)
Dr Helen Savoia	Obstetric, Neonatal and Paediatric Haematologist
Dr Janney Wale	Australian Consumers Health Forum of Australia (CHF)

The Australian and New Zealand Society of Blood Transfusion (ANZSBT) was supported by funding for this work from the Australian Government under the The Quality Use of Pathology Program (QUPP) . The ANZSBT would like to acknowledge the support and opportunity provided by the Australian Government Department of Health to be involved in the development of a roadmap and resources assisting the introduction of RHD NIPT as part of the complete pregnancy care pathway in Australia